IL37 and sarcopenia: In conclusion results herein, although preliminary and needing to be confirmed in a bigger cohort, demonstrate that rehabilitation reduces inflammation and suggest that IL-37 and its regulatory miRNAs could be used as easily accessible biomarkers to evaluate the outcome of rehabilitation protocols for sarcopenia and, possibly, as therapeutic targets in this condition.